doi: 10.1016/0014-4827(75)90404-8.
Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction
- PMID: 165958
- DOI: 10.1016/0014-4827(75)90404-8
Item in Clipboard
Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction
Exp Cell Res.
1975 May.
No abstract available
Similar articles
-
The Epstein-Barr virus (EBV): evidence for EBV strains.IARC Sci Publ (1971). 1975;(11 Pt 1):323-30. IARC Sci Publ (1971). 1975. PMID: 190135 No abstract available.
-
Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.Proc Natl Acad Sci U S A. 1977 Jan;74(1):363-6. doi: 10.1073/pnas.74.1.363. Proc Natl Acad Sci U S A. 1977. PMID: 189313 Free PMC article.
-
Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.J Natl Cancer Inst. 1982 Sep;69(3):585-90. J Natl Cancer Inst. 1982. PMID: 6287082
-
Comparative studies on the induction of virus-associated nuclear antigen and early antigen by lymphocyte-transforming (B95-8) and nontransforming (P3HR-1) strains of Epstein-Barr virus.Intervirology. 1978;9(2):86-94. doi: 10.1159/000148926. Intervirology. 1978. PMID: 201584 No abstract available.
-
An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.Intervirology. 1975;5(6):319-34. doi: 10.1159/000149930. Intervirology. 1975. PMID: 181343
Cited by
-
Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.Proc Natl Acad Sci U S A. 1990 Oct;87(19):7390-4. doi: 10.1073/pnas.87.19.7390. Proc Natl Acad Sci U S A. 1990. PMID: 2170976 Free PMC article.
-
The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.J Virol. 1992 Nov;66(11):6461-9. doi: 10.1128/JVI.66.11.6461-6469.1992. J Virol. 1992. PMID: 1328675 Free PMC article.
-
Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection.Can Med Assoc J. 1984 Nov 15;131(10):1249-52. Can Med Assoc J. 1984. PMID: 6093976 Free PMC article.
-
Mapping of genes in BamHI fragment M of Epstein-Barr virus DNA that may determine the fate of viral infection.J Virol. 1986 Jan;57(1):145-54. doi: 10.1128/JVI.57.1.145-154.1986. J Virol. 1986. PMID: 2867227 Free PMC article.
-
Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.J Virol. 1986 May;58(2):475-86. doi: 10.1128/JVI.58.2.475-486.1986. J Virol. 1986. PMID: 3009861 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
